JADA 2016-005 JADA vs J-4514

In October 2016 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4514 (the Athlete) after his sample tested positive for the prohibited substance metandienone.

After notification the Athlete admitted the intentional use of the substance, waived his right to be heard and filed a statement in his defence.

Considering the Athlete’s admission and without grounds for a reduced sanction JADA decides on 19 December 2016 to impose a 4 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 14 October 2016.

Original document

Parameters

Legal Source
National Decisions
Date
19 December 2016
Arbitrator
Suzuki, Hidenori
Original Source
Japan Anti-Doping Agency (JADA)
Country
Japan
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Admission
Waiver of "right to be heard"
Sport/IFs
Bodybuilding & Fitness (IFBB) - International Federation of Bodybuilding & Fitness
Other organisations
Japan Anti-Doping Agency (JADA)
Laboratories
Tokyo, Japan: Anti-Doping Laboratory
Doping classes
S1. Anabolic Agents
Substances
Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Document type
Pdf file
Date generated
28 March 2017
Date of last modification
22 April 2021
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin